Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Stanford Medicine · Stanford University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
579
total citations
- FWCI
- 42.95
- Percentile
- 100%
- References
- 35
Citations per year
Authors
14Topics & keywords
Topics
Keywords
- Amyotrophic lateral sclerosis
- Spinocerebellar ataxia
- Neurodegeneration
- TARDBP
- Transgene
- Neuroscience
- Genetically modified mouse
- Ataxia
No related works found for this paper.